Behavioural Intervention

Perspectives OCD for Obsessive-Compulsive Disorder

Led By Sabine Wilhelm, Ph.D.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upendpoint (week 12)
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is testing two digital health programs for OCD in order to see if they are effective and accessible treatments for the disorder.

Eligible Conditions
  • Obsessive-Compulsive Disorder


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~endpoint (week 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and endpoint (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in OCD severity (YBOCS) at the end of Week 12
Secondary outcome measures
Difference in depression at the end of Week 12
Difference in functional impairment at the end of Week 12
Difference in quality of life at the end of Week 12

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Perspectives OCDExperimental Treatment1 Intervention
12 week Smartphone-delivered CBT for OCD.
Group II: The Health and Well-Being ProgramActive Control1 Intervention
12 week health and well-being education

Find a site

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,832 Previous Clinical Trials
13,567,161 Total Patients Enrolled
26 Trials studying Obsessive-Compulsive Disorder
1,575 Patients Enrolled for Obsessive-Compulsive Disorder
Koa Health B.V.Industry Sponsor
5 Previous Clinical Trials
300 Total Patients Enrolled
Sabine Wilhelm, Ph.D.Principal Investigator
Massachusetts General Hospital
5 Previous Clinical Trials
230 Total Patients Enrolled
2 Trials studying Obsessive-Compulsive Disorder
87 Patients Enrolled for Obsessive-Compulsive Disorder

Media Library

Perspectives OCD (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04136626 — N/A
Obsessive-Compulsive Disorder Research Study Groups: Perspectives OCD, The Health and Well-Being Program
Obsessive-Compulsive Disorder Clinical Trial 2023: Perspectives OCD Highlights & Side Effects. Trial Name: NCT04136626 — N/A
Perspectives OCD (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04136626 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent can this investigation accommodate participants?

"Affirmative. currently lists this experiment as actively recruiting, having been initially posted on July 26th 2021 and last updated June 29th 2022. A total of 120 prospective participants are needed from a single test site to partake in the trial."

Answered by AI

Are there any available slots left for potential participants in this experiment?

"Yes, the public records about this trial hosted on demonstrate that recruitment is currently underway; it was first posted on July 26th 2021 and revised most recently June 29th 2022 with an aim of enrolling 120 participants from a single site."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Most responsive sites:
  1. Massachusetts General Hospital: < 24 hours
Average response time
  • < 1 Day
~38 spots leftby Sep 2024